We are live on ! Find out more
BLACU

Bellevue Life Sciences Acquisition Corp. Unit
BLACU

Delisted

BLACU was delisted on the 14th of February, 2025.

Back to rankings

13 hedge funds and large institutions have $18.1M invested in Bellevue Life Sciences Acquisition Corp. Unit in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% less capital invested

Capital invested by funds: $29.6M → $18.1M (-$11.5M)

43% less funds holding

Funds holding: 23 → 13 (-10)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 10

Holders
13
Holders Change
-10
Holders Change %
-43.48%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SIA
Schechter Investment Advisors
Michigan
+$18.2K

Top Sellers

Rank Fund Capital Flow
1
RCM
Rivernorth Capital Management
Florida
-$2.58M
2
ETH
Exos TFP Holdings
New York
-$2.06M
3
SFM
Spartan Fund Management
Canada
-$2.06M
4
RCM
Radcliffe Capital Management
Pennsylvania
-$1.55M
5
SCM
Shaolin Capital Management
Florida
-$1.13M

BLACU Hedge Fund Activity: Q2 2023 in Review

13 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Bellevue Life Sciences Acquisition Corp. Unit (BLACU) for Q2 2023, worth a combined $18.1M — down 39% from $29.6M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of BLACU and 0 opened new positions — a net loss of 10 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Schechter Investment Advisors, adding an estimated $18.2K. The largest seller was Rivernorth Capital Management, exiting entirely with an estimated $2.58M sold.

  • 13 institutional investors held Bellevue Life Sciences Acquisition Corp. Unit (BLACU) as of Q2 2023, down from 23 in Q1 2023.
  • Funds reported $18.1M of Bellevue Life Sciences Acquisition Corp. Unit stock for Q2 2023, down 39% quarter-over-quarter.
  • 0 funds opened new Bellevue Life Sciences Acquisition Corp. Unit positions in Q2 2023 and 10 closed out, a net change of -10 holders.
  • The largest Bellevue Life Sciences Acquisition Corp. Unit buyer in Q2 2023 was Schechter Investment Advisors, an estimated $18.2K added.
  • The largest Bellevue Life Sciences Acquisition Corp. Unit seller in Q2 2023 was Rivernorth Capital Management, an estimated $2.58M sold.

Based on aggregated 13F filings for Q2 2023.